EVP and President, U.S. of Horizon Therapeutics Plc (30-Year Financial, Insider Trades) Daniel A. Camardo (insider trades) sold 12,900 shares of HZNP on 03/30/2021 at an average price of $85.5 a share. The total sale was $1.1 million.
Horizon Pharma PLC is a pharmaceutical company. The company focuses on researching, developing and commercializing medicines that address unmet treatment needs for rare and rheumatic diseases. Horizon Therapeutics Plc has a market cap of $20.63 billion; its shares were traded at around $92.040000 with a P/E ratio of 56.12 and P/S ratio of 8.95.
Directors and Officers Recent Trades:
- EVP and President, U.S. Daniel A. Camardo sold 12,900 shares of HZNP stock on 03/30/2021 at the average price of $85.5. The price of the stock has increased by 7.65% since.
For the complete insider trading history of HZNP, click here.